TCBPW Accounts Payable vs Property Plant And Equipment Gross Analysis

TCBPW Stock  USD 0.01  0.0004  3.23%   
TC BioPharm financial indicator trend analysis is much more than just breaking down TC BioPharm plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether TC BioPharm plc is a good investment. Please check the relationship between TC BioPharm Accounts Payable and its Property Plant And Equipment Gross accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Accounts Payable vs Property Plant And Equipment Gross

Accounts Payable vs Property Plant And Equipment Gross Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of TC BioPharm plc Accounts Payable account and Property Plant And Equipment Gross. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between TC BioPharm's Accounts Payable and Property Plant And Equipment Gross is -0.61. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Property Plant And Equipment Gross in the same time period over historical financial statements of TC BioPharm plc, assuming nothing else is changed. The correlation between historical values of TC BioPharm's Accounts Payable and Property Plant And Equipment Gross is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of TC BioPharm plc are associated (or correlated) with its Property Plant And Equipment Gross. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant And Equipment Gross has no effect on the direction of Accounts Payable i.e., TC BioPharm's Accounts Payable and Property Plant And Equipment Gross go up and down completely randomly.

Correlation Coefficient

-0.61
Relationship DirectionNegative 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents TC BioPharm obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of TC BioPharm plc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Property Plant And Equipment Gross

Most indicators from TC BioPharm's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into TC BioPharm plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TC BioPharm plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Tax Provision is likely to drop to about (1 M) in 2025. Selling General Administrative is likely to drop to about 5.1 M in 2025
 2022 2024 2025 (projected)
Depreciation And Amortization762.5K567.1K638.0K
Interest Income2.2K2.0K1.9K

TC BioPharm fundamental ratios Correlations

-0.45-0.3-0.350.480.18-0.02-0.50.18-0.20.310.17-0.440.310.49-0.050.130.05-0.540.460.1-0.290.42-0.040.610.11
-0.450.580.82-0.94-0.010.330.96-0.110.1-0.14-0.010.68-0.14-0.09-0.30.010.170.11-0.480.040.91-0.810.13-0.28-0.15
-0.30.580.92-0.38-0.67-0.30.35-0.750.470.63-0.670.920.63-0.70.27-0.71-0.550.71-0.480.60.41-0.15-0.540.32-0.74
-0.350.820.92-0.63-0.49-0.140.66-0.590.410.35-0.490.920.35-0.510.14-0.51-0.320.52-0.390.510.67-0.4-0.40.13-0.62
0.48-0.94-0.38-0.63-0.27-0.61-0.96-0.190.20.36-0.28-0.450.36-0.130.57-0.29-0.450.090.620.29-0.950.96-0.380.51-0.17
0.18-0.01-0.67-0.49-0.270.880.20.98-0.9-0.781.0-0.73-0.780.93-0.840.990.98-0.91-0.09-0.90.32-0.520.76-0.640.97
-0.020.33-0.3-0.14-0.610.880.470.85-0.85-0.630.89-0.38-0.630.74-0.980.870.93-0.71-0.52-0.890.6-0.80.8-0.640.85
-0.50.960.350.66-0.960.20.470.11-0.05-0.420.20.48-0.420.08-0.40.230.38-0.05-0.41-0.160.92-0.890.27-0.510.07
0.18-0.11-0.75-0.59-0.190.980.850.11-0.87-0.780.98-0.79-0.780.89-0.810.990.94-0.89-0.07-0.930.2-0.450.77-0.620.99
-0.20.10.470.410.2-0.9-0.85-0.05-0.870.56-0.90.670.56-0.790.83-0.84-0.880.760.30.86-0.290.43-0.610.56-0.89
0.31-0.140.630.350.36-0.78-0.63-0.42-0.780.56-0.780.521.0-0.60.51-0.83-0.820.58-0.060.75-0.310.54-0.590.89-0.77
0.17-0.01-0.67-0.49-0.281.00.890.20.98-0.9-0.78-0.72-0.780.92-0.850.990.98-0.91-0.11-0.910.32-0.530.78-0.640.97
-0.440.680.920.92-0.45-0.73-0.380.48-0.790.670.52-0.720.52-0.740.36-0.72-0.590.75-0.340.660.4-0.18-0.450.28-0.8
0.31-0.140.630.350.36-0.78-0.63-0.42-0.780.561.0-0.780.52-0.60.51-0.83-0.820.58-0.060.75-0.310.54-0.590.89-0.77
0.49-0.09-0.7-0.51-0.130.930.740.080.89-0.79-0.60.92-0.74-0.6-0.740.910.87-1.00.13-0.720.23-0.350.7-0.330.85
-0.05-0.30.270.140.57-0.84-0.98-0.4-0.810.830.51-0.850.360.51-0.74-0.82-0.880.70.570.86-0.570.76-0.830.53-0.81
0.130.01-0.71-0.51-0.290.990.870.230.99-0.84-0.830.99-0.72-0.830.91-0.820.97-0.9-0.07-0.910.3-0.540.81-0.660.97
0.050.17-0.55-0.32-0.450.980.930.380.94-0.88-0.820.98-0.59-0.820.87-0.880.97-0.85-0.2-0.890.49-0.670.77-0.720.93
-0.540.110.710.520.09-0.91-0.71-0.05-0.890.760.58-0.910.750.58-1.00.7-0.9-0.85-0.180.69-0.190.31-0.670.3-0.83
0.46-0.48-0.48-0.390.62-0.09-0.52-0.41-0.070.3-0.06-0.11-0.34-0.060.130.57-0.07-0.2-0.180.37-0.520.63-0.330.3-0.15
0.10.040.60.510.29-0.9-0.89-0.16-0.930.860.75-0.910.660.75-0.720.86-0.91-0.890.690.37-0.230.55-0.830.74-0.97
-0.290.910.410.67-0.950.320.60.920.2-0.29-0.310.320.4-0.310.23-0.570.30.49-0.19-0.52-0.23-0.910.27-0.440.16
0.42-0.81-0.15-0.40.96-0.52-0.8-0.89-0.450.430.54-0.53-0.180.54-0.350.76-0.54-0.670.310.630.55-0.91-0.580.66-0.44
-0.040.13-0.54-0.4-0.380.760.80.270.77-0.61-0.590.78-0.45-0.590.7-0.830.810.77-0.67-0.33-0.830.27-0.58-0.50.79
0.61-0.280.320.130.51-0.64-0.64-0.51-0.620.560.89-0.640.280.89-0.330.53-0.66-0.720.30.30.74-0.440.66-0.5-0.66
0.11-0.15-0.74-0.62-0.170.970.850.070.99-0.89-0.770.97-0.8-0.770.85-0.810.970.93-0.83-0.15-0.970.16-0.440.79-0.66
Click cells to compare fundamentals

TC BioPharm Account Relationship Matchups

TC BioPharm fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets7.3M8.0M11.3M8.9M10.3M10.0M
Short Long Term Debt Total2.6M15.9M2.5M1.8M1.6M1.5M
Other Current Liab3.1M9.6M7.3M2.5M2.8M5.1M
Total Current Liabilities4.2M20.6M9.2M4.8M5.5M9.4M
Total Stockholder Equity(3.3M)(16.6M)331.3K2.7M3.1M3.2M
Property Plant And Equipment Net4.6M3.7M3.3M2.6M2.4M3.2M
Current Deferred Revenue2.0M2.0M1.3M(305.3K)(274.8K)(261.1K)
Net Debt1.8M14.3M(2.4M)(661.5K)(595.3K)(565.5K)
Retained Earnings(19.9M)(33.5M)(33.4M)(38.8M)(35.0M)(36.7M)
Accounts Payable638.4K1.4M882.4K1.8M2.1M1.2M
Cash748.0K1.6M4.8M2.5M2.8M2.3M
Non Current Assets Total5.0M4.2M3.8M3.2M2.9M3.6M
Cash And Short Term Investments748.0K1.6M4.8M2.5M2.8M2.3M
Net Receivables1.2M1.5M1.8M1.2M1.1M1.4M
Common Stock Shares Outstanding11.2M7.8M13.7M123.6M142.1M149.2M
Liabilities And Stockholders Equity7.3M8.0M11.3M8.9M10.3M10.0M
Non Current Liabilities Total6.4M4.0M1.8M1.5M1.3M1.3M
Capital Lease Obligations3.0M2.9M2.1M1.8M1.6M2.1M
Inventory(1.2M)(1.5M)(1.8M)(1.2M)(1.4M)(1.5M)
Other Current Assets230.7K811.3K836.1K4.1M4.7M4.9M
Total Liab10.6M24.6M11.0M6.2M5.6M10.4M
Net Invested Capital(3.3M)(9.8M)627.8K2.7M3.1M3.2M
Property Plant And Equipment Gross6.9M6.7M6.5M6.8M6.1M5.4M
Total Current Assets2.2M3.9M7.4M5.7M6.6M5.2M
Capital Stock1.8M195.5K397.5K2.1K1.9K1.8K
Net Working Capital(2.0M)(16.7M)(1.7M)950.3K1.1M1.1M
Short Term Debt442.7K7.6M981.5K305.3K351.1K333.6K
Intangible Assets423.8K483.6K553.0K615.2K707.4K523.9K
Common Stock194.6K195.5K397.5K2.1K1.9K1.8K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TCBPW Stock Analysis

When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.